day 2: track 2, patient’s role, dave leventhal (pfizer) jane larkindale, jeffrey sherman,
Published 8 years ago • 183 plays • Length 41:39Download video MP4
Download video MP3
Similar videos
-
19:19
let's get vascular: part ii
-
3:08:36
evm virtual interactive: day 2 - various
-
1:54
diagnosing type 2 diabetes
-
7:36
introducing remission - type 2 diabetes
-
1:46
a4m 30th annual spring congress: module v with james lavalle, rph
-
1:12
vascular medicine: a companion to braunwald's heart disease, 2nd edition
-
0:31
adrenalin ver2
-
1:28:47
race oncology (asx:rac) 2024 annual general meeting
-
17:31
what is neuropathy: definition, symptoms, causes, and diagnosis
-
5:22
dr. tony gasparis on differential diagnosis of swollen leg and diagnostic algorithm
-
3:04
the logistical challenges of car t-cell therapy in non-hodgkin lymphoma
-
1:07
promising investigational car-t approaches for myeloma: dual-targeted car-t products
-
1:46
assessing financial toxicity of car-t therapy in myeloma and improving access to this treatment
-
5:44
the changing approach to infection management with the influx of novel immunotherapies in myeloma
-
4:40
can a continuous glucose monitor (cgm) be used to improve skin health and appearance?
-
2:04
the impact and value of whole genome sequencing in multiple myeloma
-
6:22
conavi medical unveils next-gen dual-modality catheter for cardiac interventions
-
2:37
the importance of secondary cancer screening programs in hodgkin lymphoma survivors
-
1:01:40
clinician track-diagnosis & management of inherited blood disorders in low medium resource countries
-
6:05
race oncology on rc220 ethics, 2024 milestones and 2025 outlook
-
2:13
future ready medicine: 2024 center for digital health symposium highlight reel
-
11:27
e. david crawford - the history of radar 1 through 7 pathways and publications